<DOC>
	<DOC>NCT00804726</DOC>
	<brief_summary>The objective of this 12-month clinical investigation is to evaluate the safety and effectiveness of the Bausch &amp; Lomb Akreos MI Five-O intraocular lens (IOL). Effectiveness will be shown through the demonstration of accurate distance correction and safety will be demonstrated through the monitoring of adverse events.</brief_summary>
	<brief_title>Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<criteria>Subjects must have a clinically documented diagnosis of agerelated cataract. Subjects must have clear intraocular media other than cataract. Subjects must be undergoing primary inthebag intraocular lens implantation for the correction of aphakia following continuous curvilinear anterior capsulotomy and phacoemulsification cataract extraction. Subjects with any anterior segment pathology for which extracapsular phacoemulsification cataract surgery would be contraindicated. Subjects with diagnosis of degenerative visual disorder. Subjects who have any inflammation or edema (swelling) of the cornea. Subjects with immunodeficiency disorders. Subjects who have had previous intraocular surgery in the study eye. Subjects with incomplete/damaged zonule, or with conditions associated with increased risk of zonular rupture. Subjects with chronic use of systemic steroids or immunosuppressive medications.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Cataract extraction</keyword>
	<keyword>Phacoemulsification</keyword>
</DOC>